{"id":"CHEMBL102970","canonicalSmiles":"Cc1ncc(CO)c(C=O)c1O","inchiKey":"RADKZDMFGJYCBB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXAL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyridoxal"],"crossReferences":{"PubChem":["170466865","26754377","29215199","29215200"],"Wikipedia":["Pyridoxal"],"drugbank":["DB00147"],"chEBI":["17310"]},"childChemblIds":["CHEMBL543846"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1075788","canonicalSmiles":"CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)O[C@H](C)[C@H]1O","inchiKey":"XQCGNURMLWFQJR-ZNDDOCHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1075788","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13240"],"chEBI":["4037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL107874","canonicalSmiles":"CCCCCCCCCCCCC(=O)O","inchiKey":"SZHOJFHSIKHZHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIDECANOATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tridecanoate","Tridecanoic Acid","Tridecanoic Acid Anion"],"crossReferences":{"PubChem":["144207735"],"Wikipedia":["Tridecylic_acid"],"drugbank":["DB02448"],"chEBI":["45919"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1086218","canonicalSmiles":"C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C","inchiKey":"YJDYDFNKCBANTM-QCWCSKBGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VALSPODAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Amdray"],"synonyms":["PSC 833","SDZ PSC 833","SDZ-PSC 833","Valspodar"],"crossReferences":{"drugbank":["DB11869"],"chEBI":["8985"]},"count":18,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 18 investigational indications."}
{"id":"CHEMBL1090173","canonicalSmiles":"O=C(CO)N1CCC(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1","inchiKey":"CATQHDWESBRRQA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SD-0006","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SD-0006","Sd-0006"],"crossReferences":{"PubChem":["174007108"],"drugbank":["DB07943"],"chEBI":["82712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1096146","canonicalSmiles":"CCC/N=C1\\S/C(=C\\c2ccc(OC[C@H](O)CO)c(Cl)c2)C(=O)N1c1ccccc1C","inchiKey":"LPAUOXUZGSBGDU-STDDISTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PONESIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-128800","Ponesimod"],"crossReferences":{"drugbank":["DB12016"]},"count":2,"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0000676"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1096643","canonicalSmiles":"CCN(CC)CCC1(c2ccccc2)CCC(=O)NC1=O","inchiKey":"BFMBKRQFMIILCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENGLUTARIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenglutarimide"],"crossReferences":{"Wikipedia":["Phenglutarimide"],"drugbank":["DB13413"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1097999","canonicalSmiles":"CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\\[C@@H](C)[C@H](C)OC2=O","inchiKey":"MWUFVYLAWAXDHQ-HMNLTAHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-6201","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-6201","E6201","ER-806201"],"crossReferences":{"drugbank":["DB11687"]},"count":3,"linkedTargets":{"rows":["ENSG00000169032","ENSG00000095015"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001494","EFO_0000676"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL111234","canonicalSmiles":"Oc1ccc(CCc2cc(O)cc(O)c2)cc1","inchiKey":"HITJFUSPLYBJPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDRORESVERATROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4',5-Trihydroxybibenzyl","Dihydro-Resveratrol","Dihydroresveratrol"],"crossReferences":{"PubChem":["537053"],"drugbank":["DB08466"],"chEBI":["4582"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1162495","canonicalSmiles":"O=C(O)CCCC(=O)O","inchiKey":"JFCQEDHGNNZCLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTARATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glutarate"],"crossReferences":{"PubChem":["144209646","144213188"],"Wikipedia":["Glutaric_acid"],"drugbank":["DB03553"],"chEBI":["17859"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1163001","canonicalSmiles":"[3H]OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F","inchiKey":"RFHAOTPXVQNOHP-SURVTVKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[3H]FLUCONAZOLE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL106","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[3H]-Fluconazole"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1197","canonicalSmiles":"CC(CNC1CCCCC1)OC(=O)c1ccccc1","inchiKey":"DKLKMKYDWHYZTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXYLCAINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cyclaine","Hexylcaine"],"crossReferences":{"Wikipedia":["Hexylcaine"],"drugbank":["DB00473"],"chEBI":["34791"]},"childChemblIds":["CHEMBL1200715"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200375","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+]","inchiKey":"SHWNNYZBHZIQQV-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":true,"name":"EDETATE CALCIUM DISODIUM","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcium Disodium Edetate","Calcium Disodium Edta","Calcium Disodium Versenate","Calcium Edetate Sodium","Calcium Edta","Edta Calcium Disodium","Edthamil","Sodium Calcium Edetate","Sodium Calciumedetate","Versene Ca"],"synonyms":["Calcium sodium edetate hydrate","E385"],"crossReferences":{"DailyMed":["edetate%20calcium%20disodium"],"PubChem":["144205262"],"drugbank":["DB14598"]},"childChemblIds":["CHEMBL3989522"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200463","canonicalSmiles":"O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.[K+]","inchiKey":"QTAQWNSMRSLSCG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXAPROZIN POTASSIUM","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1071","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daypro alta"],"synonyms":["Oxaprozin potassium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2002."}
{"id":"CHEMBL1200530","canonicalSmiles":"CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)[O-])=C(COC(N)=O)CS[C@@H]21.[Na+]","inchiKey":"GNWUOVJNSFPWDD-XMZRARIVSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"CEFOXITIN SODIUM","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL996","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefoxitin","Mefoxin"],"synonyms":["Cefoxitin sodium"],"crossReferences":{"DailyMed":["cefoxitin%20sodium"],"PubChem":["144207034","56422171","8139890"],"chEBI":["3501"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200539","canonicalSmiles":"O=C([O-])[O-].[Ca+2]","inchiKey":"VTYYLEPIZMXCLO-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM CARBONATE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adcal","Albacar","Cacit","Cal-sup","Calc 500","Calcette","Calcichew","Calcichew fte","Calcidrink","Children's mylanta upset stomach relief","Chooz","Citrical","Mylanta soothing lozenges","Os-cal","Precipitated Calcium Carbonate","Purecal","Remegel","Rennie","Rennie fruit","Rennie gold","Setlers","Titralac","Tums"],"synonyms":["Calcium carbonate","Chalk","Chalk, precipitated","E-170(I)","E170","INS NO.170(I)","INS-170(I)","NDI 443","Precipitated calcium carbonate","Precpitated calcium carbonate"],"crossReferences":{"DailyMed":["calcium%20carbonate"],"DrugCentral":["4239"],"Wikipedia":["Calcium_carbonate"],"drugbank":["DB06724"],"chEBI":["3311"]},"count":20,"approvedIndications":["EFO_0004272","EFO_0003882"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for anemia (phenotype) and osteoporosis and has 18 investigational indications."}
{"id":"CHEMBL1200614","canonicalSmiles":"O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I","inchiKey":"AMDBBAQNWSUWGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOVERSOL","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Optiray","Optiray 160","Optiray 240","Optiray 300","Optiray 320","Optiray 350"],"synonyms":["Ioversol","MP 328","MP-328"],"crossReferences":{"DailyMed":["ioversol"],"PubChem":["170464725"],"Wikipedia":["Ioversol"],"drugbank":["DB09134"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200641","canonicalSmiles":"COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1","inchiKey":"XXZSQOVSEBAPGS-DONVQRBFSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CISATRACURIUM BESYLATE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201248","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cisatracurium besylate","Cisatracurium besylate preservative free","Nimbex","Nimbex preservative free"],"synonyms":["51 W89","51-W-89","51-W89","51W-89","51W89","Cisatracurium besilate","Cisatracurium besylate"],"crossReferences":{"DailyMed":["cisatracurium%20besylate"],"PubChem":["11113043"],"chEBI":["3721"]},"count":1,"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["EFO_1000992","EFO_0000694","EFO_0005323","EFO_1001905","EFO_1000637"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and has 1 investigational indication."}
{"id":"CHEMBL1200761","canonicalSmiles":"COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1","inchiKey":"BFPSDSIWYFKGBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROTRIANISENE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorotrianisene","Tace"],"synonyms":["Chlorotrianisene","Chlortrianisestrol","NSC-10108","Trianisestrol"],"crossReferences":{"PubChem":["104171308","11112416","11532856","124882352","144204017","144209559","144213214","170465394","17389725","26747338"],"Wikipedia":["Chlorotrianisene"],"drugbank":["DB00269"],"chEBI":["3641"]},"count":2,"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0000182","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 2 investigational indications."}
{"id":"CHEMBL1200983","drugType":"Small molecule","blackBoxWarning":true,"name":"GALLIUM NITRATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ganite"],"synonyms":["Gallium nitrate","Gallium nitrate nonahydrate","NSC-15200"],"crossReferences":{"DailyMed":["gallium%20nitrate"],"DrugCentral":["5115"],"Wikipedia":["Gallium_nitrate"]},"childChemblIds":["CHEMBL1697699"],"count":6,"linkedTargets":{"rows":["ENSG00000171848"],"count":1},"linkedDiseases":{"rows":["EFO_0000574","Orphanet_586","EFO_0005952","EFO_0009429","EFO_0000691","EFO_0000621"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200988","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21.[Br-]","inchiKey":"PQMWYJDJHJQZDE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHANTHELINE BROMIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201264","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Banthine"],"synonyms":["Dixamone bromide","Methantheline bromide","Methanthelinium bromide"],"crossReferences":{"PubChem":["144203871","170465350","56463185"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951."}
{"id":"CHEMBL1201052","canonicalSmiles":"CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21.O=S(=O)(O)c1ccccc1","inchiKey":"CRJHBCPQHRVYBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MESORIDAZINE BESYLATE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1088","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Serentil"],"synonyms":["Mesoridazine besylate"],"crossReferences":{"PubChem":["26719781","85273786"],"chEBI":["6781"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201138","canonicalSmiles":"Nc1nc(O)c2c(n1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1)N2C=O.[Ca+2]","inchiKey":"KVUAALJSMIVURS-ZEDZUCNESA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUCOVORIN CALCIUM","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1679","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calc folinate","Folacal","Fusilev","Leucovorin calcium","Leucovorin calcium preservative free","Wellcovorin"],"synonyms":["Calcium folinate","Calcium folinate pentahydrate","Citrovorum factor","Folic acid related compound a","Folinate-sf calcium","Folinic acid","Folinic acid calcium salt pentahydrate","Leucovorin calcium","NSC-3590"],"crossReferences":{"DailyMed":["leucovorin%20calcium"],"PubChem":["538664"]},"count":91,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 91 investigational indications."}
{"id":"CHEMBL1201334","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O","inchiKey":"VXKHXGOKWPXYNA-PGBVPBMZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TRIPTORELIN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decapeptyl","Decapeptyl sr","Gonapeptyl depot"],"synonyms":["AY-25650","CL 118,532","CL-118532","Triptorelin","WY-42462"],"crossReferences":{"DailyMed":["triptorelin%20pamoate"],"PubChem":["50112597"],"Wikipedia":["Triptorelin"],"drugbank":["DB06825"],"chEBI":["63633"]},"childChemblIds":["CHEMBL1200554"],"count":13,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","Orphanet_64739","EFO_0000545","EFO_0001065","EFO_0008560","EFO_0000180","MONDO_0007254","MONDO_0004669","EFO_0009867","EFO_0000305","MONDO_0008315","EFO_0001663","HP_0004322","EFO_0009029","EFO_0000512","MONDO_0000088","EFO_0000673","EFO_0000574"],"count":18},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for neoplasm and has 12 investigational indications."}
{"id":"CHEMBL1201353","canonicalSmiles":"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1","inchiKey":"SOYKEARSMXGVTM-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXCHLORPHENIRAMINE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorpheniramine d-form","Dexchlorpheniramine"],"crossReferences":{"DailyMed":["dexchlorpheniramine%20maleate"],"PubChem":["29216403","90340867"],"Wikipedia":["Dexchlorpheniramine"],"drugbank":["DB13679"],"chEBI":["4464"]},"childChemblIds":["CHEMBL1200927","CHEMBL3183101"],"count":4,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003885","EFO_0005531","EFO_0003958","EFO_0007533","MONDO_0024352","EFO_0007141","EFO_0005532","EFO_1001417","MONDO_0008315","EFO_0003785","EFO_0003956"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for allergy and has 3 investigational indications."}
{"id":"CHEMBL1201414","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"TINZAPARIN SODIUM","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Innohep","Logiparin"],"synonyms":["LNH-1","LNH1","Tinzaparin","Tinzaparin sodium"],"crossReferences":{"Wikipedia":["Tinzaparin_sodium"]},"count":8,"approvedIndications":["EFO_0003907","HP_0004419"],"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0000365","HP_0002140","EFO_0004286","EFO_0000495","EFO_0003060","EFO_0003106","HP_0001907","MONDO_0100096","MONDO_0000831","EFO_0003827","EFO_0003884","MONDO_0002367","EFO_0003907","EFO_0001378","HP_0004419","EFO_0000400","HP_0004936"],"count":17},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for recurrent thrombophlebitis and deep vein thrombosis and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201461","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROMETHORPHAN POLISTIREX","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL52440","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delsym","Dextromethorphan polistirex"],"synonyms":["Dextromethorphan polistirex"],"crossReferences":{"DailyMed":["dextromethorphan%20polistirex"]},"count":1,"linkedTargets":{"rows":["ENSG00000183454","ENSG00000147955"],"count":2},"linkedDiseases":{"rows":["EFO_0003756"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1201509","drugType":"Protein","blackBoxWarning":false,"name":"GONADOTROPIN, CHORIONIC","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A.p.l.","Choragon","Chorionic gonadotropin","Equine Chorionic Gonadotropin","Follutein","Gonadotraphon lh","Human Chorionic Gonadotropin","Pregnyl","Profasi","Profast","Progestyl"],"synonyms":["Choriogonadotropin beta","Chorionic gonadotrophin","Gonadotropin, chorionic"],"crossReferences":{"DailyMed":["gonadotropin,%20chorionic"],"DrugCentral":["5196"]},"count":9,"linkedTargets":{"rows":["ENSG00000138039"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","Orphanet_64739","MONDO_0002259","EFO_0000545","MONDO_0002146","EFO_0000279","MONDO_0007254","MONDO_0002775","Orphanet_478","EFO_0000660","MONDO_0018555","EFO_0002950"],"count":12},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 9 investigational indications."}
{"id":"CHEMBL1201541","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Protamine zinc and iletin ii","Protamine zinc insulin"],"synonyms":["Insulin susp protamine zinc purified beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1980."}
{"id":"CHEMBL1201564","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON GAMMA-1B","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actimmune","Immukin"],"synonyms":["Interferon .gamma.-1b","Interferon gama-1b","Interferon gamma","Interferon gamma-1b","Interferon gamma-2a"],"crossReferences":{"DailyMed":["interferon%20gamma-1b"],"Wikipedia":["Interferon-gamma"]},"count":40,"approvedIndications":["Orphanet_53","Orphanet_2781","Orphanet_379"],"linkedTargets":{"rows":["ENSG00000159128","ENSG00000027697"],"count":2},"linkedDiseases":{"rows":["EFO_0000637","EFO_0007183","MONDO_0015686","EFO_0000756","EFO_0000768","MONDO_0007254","Orphanet_586","EFO_0005952","MONDO_0002087","EFO_1001951","EFO_0000565","MONDO_0002158","EFO_0000588","EFO_0000389","EFO_0000676","EFO_0002918","EFO_0009429","Orphanet_379","EFO_0009869","EFO_0000616","EFO_1000811","EFO_1001359","MONDO_0008170","EFO_0004197","Orphanet_95","EFO_0000621","EFO_0009448","MONDO_0008315","Orphanet_398934","EFO_0001422","EFO_0007228","EFO_0004220","Orphanet_53","EFO_0007460","EFO_1001231","EFO_0000174","EFO_0000764","EFO_0000574","MONDO_0004580","EFO_1001051","Orphanet_2781","EFO_0001378","EFO_0007386"],"count":43},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 37 investigational indications."}
{"id":"CHEMBL1201603","drugType":"Small molecule","blackBoxWarning":false,"name":"CRYPTENAMINE TANNATES","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Unitensen"],"synonyms":["Cryptenamine tannates"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201606","drugType":"Antibody","blackBoxWarning":false,"name":"IBRITUMOMAB TIUXETAN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zevalin","Zevalin Kit-Indium-111"],"synonyms":["IDEC-129","IDEC-IN2B8","IDEC-Y2B8","IDEC-Y2B8 IDEC-129","Ibritumomab tiuxetan"],"crossReferences":{"DailyMed":["ibritumomab%20tiuxetan"],"DrugCentral":["4984"],"Wikipedia":["Ibritumomab_tiuxetan"]},"count":16,"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","MONDO_0013730","MONDO_0000873","MONDO_0019465","EFO_0000403","EFO_1001469","EFO_0005952","EFO_0000565","EFO_0000309","EFO_1001365","EFO_0000096","EFO_0000095","MONDO_0019088","EFO_0000191","EFO_0000574","MONDO_0018906","EFO_0001378","EFO_0000183","EFO_1000550"],"count":19},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 16 investigational indications."}
{"id":"CHEMBL1201823","drugType":"Protein","blackBoxWarning":false,"name":"ABATACEPT","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orencia","Orencia clickject"],"synonyms":["Abatacept","Abatacept (genetical recombination)","BMS-188667","CTLA4-IGG4M","RG-1046","RG-2077"],"crossReferences":{"DailyMed":["abatacept"],"DrugCentral":["5089"],"Wikipedia":["Abatacept"]},"count":35,"approvedIndications":["EFO_0000685","EFO_0000540","EFO_0002609"],"linkedTargets":{"rows":["ENSG00000121594","ENSG00000114013"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_1001494","EFO_0003780","EFO_0010638","EFO_0003778","EFO_0000540","EFO_1001486","EFO_1001148","EFO_0005676","EFO_0008518","EFO_0005531","EFO_0002690","MONDO_0017287","EFO_0004255","EFO_0000676","Orphanet_700","EFO_0004826","EFO_0004208","EFO_0004991","EFO_0009730","Orphanet_797","MONDO_0013730","EFO_0000685","EFO_0005761","EFO_1001857","EFO_0003898","EFO_0003929","EFO_0000384","EFO_0005755","EFO_0002609","EFO_0000537","EFO_1001209","EFO_0003885","EFO_1001231","EFO_0000404","EFO_0004192","MONDO_0100096","EFO_0000398","EFO_0005297","EFO_0001359","EFO_0001378","EFO_0000699"],"count":42},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 32 investigational indications."}
{"id":"CHEMBL1201830","drugType":"Protein","blackBoxWarning":false,"name":"RILONACEPT","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arcalyst"],"synonyms":["IL-1 TRAP","IL-1-TRAP","INTERLEUKIN-1 TRAP","Rilonacept"],"crossReferences":{"DailyMed":["rilonacept"],"DrugCentral":["5105"],"Wikipedia":["Rilonacept"]},"count":12,"approvedIndications":["Orphanet_575","Orphanet_47045","Orphanet_208650","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000125538"],"count":1},"linkedDiseases":{"rows":["Orphanet_575","EFO_0004274","EFO_1001345","EFO_0000540","EFO_0002609","Orphanet_210115","EFO_0000404","EFO_1001999","EFO_0001359","EFO_0003884","Orphanet_47045","Orphanet_208650","EFO_0007427","EFO_0004238","Orphanet_342","EFO_1001881"],"count":16},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 4 approved and 8 investigational indications."}
{"id":"CHEMBL1213652","canonicalSmiles":"[3H]C(O)[C@H]1N[C@@H](c2c[nH]c3c(=O)[nH]cnc23)[C@H](O)[C@@H]1O","inchiKey":"IWKXDMQDITUYRK-ITZIIZASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213652","maximumClinicalTrialPhase":0,"parentId":"CHEMBL218291","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1224151","canonicalSmiles":"COc1cc(/C=C2\\CCCN([C@@H](C)c3ccc(F)cc3)C2=O)ccc1-n1cnc(C)c1","inchiKey":"PUOAETJYKQITMO-LANLRWRYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1224151","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05171"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230787","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"KTVPXOYAKDPRHY-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230787","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04127"],"chEBI":["40438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232414","canonicalSmiles":"CC(=O)[C@@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"AJPADPZSRRUGHI-RFZPGFLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232414","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02496"],"chEBI":["16493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234696","canonicalSmiles":"O=[N+]([O-])c1ccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2F)c([N+](=O)[O-])c1","inchiKey":"UFSBFVZQJZMIOU-LZQZFOIKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234696","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50106143","50106144","90340709"],"drugbank":["DB02658"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235106","canonicalSmiles":"CCOCCOCCOCC","inchiKey":"RRQYJINTUHWNHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235106","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212367"],"drugbank":["DB08357"],"chEBI":["44664"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235551","canonicalSmiles":"O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3[C@@H]2C1","inchiKey":"FSVJFNAIGNNGKK-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAZIQUANTEL, (R)-","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arpraziquantel","MSC-2499550A","MSC2499550A","Msc2499550a","Praziquantel, (r)-"],"crossReferences":{"PubChem":["11111633","11112791"],"drugbank":["DB11749"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235702","canonicalSmiles":"CC[C@H](CO)Nc1nc(N(C)Cc2ccccc2)c2ncn(C(C)C)c2n1","inchiKey":"YPYWONAECUVKHY-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235702","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04776"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235981","canonicalSmiles":"O=C(O)/C=C/c1ccc(O)cc1O","inchiKey":"HGEFWFBFQKWVMY-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(E)-2,4-Dihydroxycinnamic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(E)-2,4-Dihydroxycinnamic Acid"],"crossReferences":{"drugbank":["DB01704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236469","canonicalSmiles":"N[C@@H](Cc1cc(I)c(O)c(I)c1)C(=O)O","inchiKey":"NYPYHUZRZVSYKL-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIOTYROSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diiodotyrosine"],"crossReferences":{"PubChem":["144206612","170466794","26756458","8139971"],"drugbank":["DB03374"],"chEBI":["15768"]},"childChemblIds":["CHEMBL2104305","CHEMBL2146096"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1236909","canonicalSmiles":"N[C@@H](Cc1ccc(O)c(F)c1)C(=O)O","inchiKey":"VIIAUOZUUGXERI-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236909","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04436"],"chEBI":["46534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237054","canonicalSmiles":"CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@@H]2C[C@@H](O)[C@@H](O[C@@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@H](O)[C@@H](C)O1","inchiKey":"XDKMHMINQXATOR-RCFLUEAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLICAMYCIN","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mithracin"],"synonyms":["A-2371","ANTIBIOTIC LA-7017","LA-7017","Mithramycin","NSC-24559","PA-144","Plicamycin"],"count":2,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for neoplasm and has 1 investigational indication."}
{"id":"CHEMBL130","canonicalSmiles":"O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl","inchiKey":"WIIZWVCIJKGZOK-RKDXNWHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAMPHENICOL","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Hematological toxicity"],"year":2012},"tradeNames":["Amphicol","Brochlor","Brolene antibiotic","Chloramex","Chloramphenicol","Chlorbiotic","Chlorofair","Chloromycetin","Chloroptic","Chloroptic s.o.p.","Econochlor","Golden eye antibiotic","Kemicetine","Kernispray","Klorafect","Mychel","Ophthochlor","Optomycin","Sno phenicol","Tevcocin","Tubilux infected eyes"],"synonyms":["Chloramphenicol","Mychel-S","NSC-16331","NSC-3069"],"crossReferences":{"PubChem":["144204859","144214022","17389985","26752873","47193729","49734345","50105494","69616"],"TG-GATEs":["64"],"Wikipedia":["Chloramphenicol"],"drugbank":["DB00446"],"chEBI":["17698"]},"childChemblIds":["CHEMBL2205638"],"count":4,"approvedIndications":["EFO_0000771","EFO_1001888","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 3 approved and 1 investigational indication. It was withdrawn in United States  in 2012 due to Hematological toxicity."}
{"id":"CHEMBL1331366","canonicalSmiles":"NC(=O)Nc1ccc([As](=O)(O)O)cc1","inchiKey":"WWXBHTZSYYGCSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBARSONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["104171295","11112267","144203955","144208247","170466507","17389993","26725287","91233"],"drugbank":["DB11382"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL134713","canonicalSmiles":"COc1ccc(/C=C2\\CCCN=C2c2cccnc2)c(OC)c1","inchiKey":"RPYWXZCFYPVCNQ-RVDMUPIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GTS-21","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-(2,4-Dimethoxybenzylidene)Anabaseine","Dmxb-a","Gts-21"],"crossReferences":{"drugbank":["DB05708"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1378024","canonicalSmiles":"CCCc1cc(C(N)=S)ccn1","inchiKey":"VRDIULHPQTYCLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTIONAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ektebin","Peteha","Trevintix"],"synonyms":["Prothionamide","Protionamide","RP 9778","RP-9778","TH-1321"],"crossReferences":{"PubChem":["121269830","144205016","170465795","174006232","26749033","50085874","865168"],"drugbank":["DB12667"]},"count":1,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for tuberculosis."}
{"id":"CHEMBL1388","canonicalSmiles":"Oc1ccc(OCc2ccccc2)cc1","inchiKey":"VYQNWZOUAUKGHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOBENZONE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benoquin"],"synonyms":["Monobenzone","Monobenzyl ether of hydroquinone","P-benzyloxyphenol"],"crossReferences":{"PubChem":["11112252","144203947","144208345","170464724","174006811"],"Wikipedia":["Monobenzone"],"drugbank":["DB00600"],"chEBI":["34380"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1952."}
{"id":"CHEMBL1399","canonicalSmiles":"CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1","inchiKey":"YBBLVLTVTVSKRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANASTROZOLE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anastrozole","Arimidex","Nastrosa"],"synonyms":["Anastrozole","Arimidex","ICI D1033","ICI-D1033","ZD-1033","ZD1033"],"crossReferences":{"DailyMed":["anastrozole"],"PubChem":["144205791","144213873","170464923","174007355","26719808"],"Wikipedia":["Anastrozole"],"drugbank":["DB01217"],"chEBI":["2704"]},"count":27,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000137869"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001361","EFO_0001065","MONDO_0007254","MONDO_0024879","EFO_0000305","HP_0000771","Orphanet_478","MONDO_0002146","MONDO_0000088","EFO_0001380","EFO_0000616","EFO_0000186","MONDO_0004658","Orphanet_562","MONDO_0008170","EFO_1001512","EFO_0000313","MONDO_0004379","MONDO_0002775","EFO_0000311","EFO_0000537","EFO_0000195","GO_0007568","HP_0004322","EFO_0000304","EFO_0000553","EFO_0006861","EFO_1001100","EFO_0005537","MONDO_0011962","EFO_0000432"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 5 approved and 22 investigational indications."}
{"id":"CHEMBL14935","canonicalSmiles":"O=C(O)[C@@H]1C[C@H]2C[C@@H](CCc3nn[nH]n3)CC[C@H]2CN1","inchiKey":"ZXFRFPSZAKNPQQ-YTWAJWBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEZAMPANEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-293,558","LY-293558","NGX-424"],"crossReferences":{"drugbank":["DB06354"]},"childChemblIds":["CHEMBL3989703"],"count":1,"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000164418","ENSG00000171189","ENSG00000105737","ENSG00000149403","ENSG00000155511","ENSG00000152578","ENSG00000163873"],"count":9},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1512580","canonicalSmiles":"FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccccc4c3)CC2)c1","inchiKey":"WJJYZXPHLSLMGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XALIPRODEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR 57746","SR-57746","Xaliproden"],"crossReferences":{"PubChem":["50112828","50112829"],"drugbank":["DB06393"],"chEBI":["48520"]},"childChemblIds":["CHEMBL3183486"],"count":2,"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_0000249","EFO_0004142"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1570266","canonicalSmiles":"CCCC(=O)OC(C(Cl)(Cl)Cl)P(=O)(OC)OC","inchiKey":"BKAQXYNWONVOAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butonate","ENT-20852"],"crossReferences":{"PubChem":["144205461","29216254"],"drugbank":["DB11379"],"chEBI":["82106"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15722","canonicalSmiles":"Cc1cccnc1","inchiKey":"ITQTTZVARXURQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-METHYLPYRIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Picoline"],"crossReferences":{"PubChem":["144209164","144213318","17389601","49718209"],"Wikipedia":["3-Methylpyridine"],"drugbank":["DB01996"],"chEBI":["39922"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1614658","canonicalSmiles":"NC(=O)OC[C@@H]1[C@H](NC(=O)/C(=N\\OCC(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O","inchiKey":"UIMOJFJSJSIGLV-JNHMLNOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARUMONAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carumonam"],"crossReferences":{"drugbank":["DB13553"],"chEBI":["55486"]},"childChemblIds":["CHEMBL2104060"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1617398","canonicalSmiles":"Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F","inchiKey":"NOOCSNJCXJYGPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNIXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flunixin","SCH 14714"],"crossReferences":{"drugbank":["DB11518"],"chEBI":["76138"]},"childChemblIds":["CHEMBL3561935","CHEMBL2358115","CHEMBL1733447","CHEMBL1314975"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1619017","canonicalSmiles":"COc1ccc2c(c1)c1c3n2CCN(C)C3=NCC1","inchiKey":"GVXBHSBKKJRBMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METRALINDOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metralindole"],"crossReferences":{"PubChem":["144204537","170466367","29215095"],"drugbank":["DB09306"]},"childChemblIds":["CHEMBL1388946"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1621","canonicalSmiles":"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O","inchiKey":"PMXMIIMHBWHSKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PALIPERIDONE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Invega","Paliperidone","Trevicta","Xeplion"],"synonyms":["Paliperidone","R-76477","RO-76477","RO76477","Risperidone impurity, 9-hydroxyrisperidone-"],"crossReferences":{"DailyMed":["paliperidone"],"PubChem":["90341688"],"Wikipedia":["Paliperidone"],"drugbank":["DB01267"],"chEBI":["83804"]},"count":9,"approvedIndications":["EFO_0005407","EFO_0000692","EFO_0005411"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0002050","HP_0000726","EFO_0000677","EFO_0003758","EFO_0005407","EFO_0001358","EFO_0004701","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0005411"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1650559","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CCN)OC[C@]1(C)O","inchiKey":"IYDYFVUFSPQPPV-PEXOCOHZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PLAZOMICIN","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ACHN-490","Plazomicin"],"crossReferences":{"drugbank":["DB12615"]},"childChemblIds":["CHEMBL2364623"],"count":3,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for bacterial disease and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1667","canonicalSmiles":"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O","inchiKey":"RSFGNDXWVZPKJA-KVBHIGNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALISKIREN FUMARATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1639","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aliskiren hemifumarate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1672","canonicalSmiles":"COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\OC)c3csc(N)n3)[C@H]2SC1","inchiKey":"WYUSVOMTXWRGEK-HBWVYFAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPODOXIME","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orelox","Orelox paed"],"synonyms":["Cefpodoxime"],"crossReferences":{"Wikipedia":["Cefpodoxime"],"drugbank":["DB01416"],"chEBI":["3504"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1697834","canonicalSmiles":"Cc1cc(=O)n(-c2ccccc2)n1C.OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl","inchiKey":"ATKXDQOHNICLQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLORALPHENAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dichloralphenazone"],"crossReferences":{"drugbank":["DB01495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742998","drugType":"Antibody","blackBoxWarning":false,"name":"CANTUZUMAB RAVTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cantuzumab ravtansine","HUC242-DM4","IMGN-242","IMGN242"],"count":3,"linkedTargets":{"rows":["ENSG00000185499"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0001056","EFO_0000365","MONDO_0003219"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743049","drugType":"Antibody","blackBoxWarning":false,"name":"OLARATUMAB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lartruvo"],"synonyms":["IMC-3G3","IMC3G3","Olaratumab"],"crossReferences":{"DailyMed":["olaratumab"],"DrugCentral":["5183"]},"count":11,"approvedIndications":["EFO_0000616","EFO_1001968","EFO_0000691"],"linkedTargets":{"rows":["ENSG00000134853"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0003893","EFO_0000564","Orphanet_44890","EFO_1001968","EFO_0000691","EFO_0003060","MONDO_0008315","EFO_0000519","EFO_0009708"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 3 approved and 8 investigational indications."}
{"id":"CHEMBL19019","canonicalSmiles":"O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","inchiKey":"DQCKKXVULJGBQN-XFWGSAIBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NALTREXONE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Celupan","Trexal","Trexan","Vivitrol"],"synonyms":["EN-1639A","EN-1639A FREE BASE","EN-1639A [AS HYDROCHLORIDE]","Naltrexone","Revia"],"crossReferences":{"DailyMed":["naltrexone","naltrexone%20hydrochloride"],"PubChem":["144205560","170465207"],"drugbank":["DB00704"],"chEBI":["7465"]},"childChemblIds":["CHEMBL1201149","CHEMBL4303313"],"count":37,"approvedIndications":["MONDO_0002046","EFO_0003829"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0000729","EFO_0004240","EFO_0002610","EFO_0005687","MONDO_0002009","EFO_0001065","EFO_0008507","MONDO_0007254","EFO_0003768","EFO_0000274","EFO_1000637","EFO_0003829","MONDO_0002046","EFO_0007191","MONDO_0002050","MONDO_0021698","EFO_0000676","EFO_0003761","EFO_0007224","HP_0012167","EFO_0004701","EFO_0004242","MONDO_0000594","EFO_0000692","EFO_0003888","EFO_0005203","EFO_0000694","EFO_0000685","HP_0012532","HP_0012076","EFO_0004329","EFO_1000906","EFO_0003821","EFO_0001358","EFO_0010702","HP_0100716","EFO_0001073","EFO_0003843","EFO_0000384","HP_0031844","EFO_0003885","EFO_0003890","MONDO_0100096","EFO_0000764","EFO_0005611","EFO_0004699"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for alcohol dependence and alcohol abuse and has 35 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1914489","canonicalSmiles":"CC(=O)Nc1cccc2c1c(Sc1ccc(Cl)cc1)c(C)n2CC(=O)O","inchiKey":"JWYIGNODXSRKGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD1981","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-1981","Azd 1981","Azd1981"],"crossReferences":{"drugbank":["DB11946"]},"count":4,"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0000545","EFO_0000270","EFO_0000341"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1922096","canonicalSmiles":"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1.CS(=O)(=O)O","inchiKey":"OZRVQTBMLHRDIR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1922096","maximumClinicalTrialPhase":0,"parentId":"CHEMBL521851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL194014","canonicalSmiles":"CCCOC(=O)c1ccc(O)cc1","inchiKey":"QELSKZZBTMNZEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPYLPARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E216","Propyl parahydroxybenzoate","Propylparaben"],"crossReferences":{"PubChem":["124890245","144204599","144213973","17388756","17389533","26752854","56436659"],"Wikipedia":["Propylparaben"],"drugbank":["DB14177"],"chEBI":["32063"]},"childChemblIds":["CHEMBL2107021"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19490","canonicalSmiles":"Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1","inchiKey":"ZXVNMYWKKDOREA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOMEPIRAC","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Spain"," Germany "],"classes":["Immune system toxicity"],"year":1983},"tradeNames":[],"synonyms":["Zomepirac"],"crossReferences":{"PubChem":["26752779"],"Wikipedia":["Zomepirac"],"drugbank":["DB04828"],"chEBI":["35859"]},"childChemblIds":["CHEMBL3989403","CHEMBL266459"],"count":1,"approvedIndications":["EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980 and is indicated for rheumatic disease. It was withdrawn in United States,  United Kingdom,  United States,  Spain and  Germany  initially in 1983 due to Immune system toxicity."}
{"id":"CHEMBL196526","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(C(F)(F)P(=O)(O)O)cc1)C(N)=O","inchiKey":"KPMMESISHWWXNM-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL196526","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07651"],"chEBI":["47379"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1966423","canonicalSmiles":"CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12.CS(=O)(=O)O","inchiKey":"LMWPNWPFYVCINS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1966423","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1107","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["453893"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL202930","canonicalSmiles":"COc1cc(-c2ccc3c(c2)NC(=O)/C3=C\\c2ccc[nH]2)ccc1O","inchiKey":"AYSXURJZVXBSRV-WJDWOHSUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"A-432411","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-432411"],"crossReferences":{"drugbank":["DB07078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2079588","canonicalSmiles":"CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1","inchiKey":"QFCXANHHBCGMAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 57-9352","BAY-579352","Bay-57-9352","Telatinib"],"crossReferences":{"PubChem":["124955475"],"drugbank":["DB15393"]},"count":2,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000037280","ENSG00000113721","ENSG00000157404"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103744","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.O.O.O.O.O.O=S(=O)(O)O","inchiKey":"GRVOTVYEFDAHCL-RTSZDRIGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MORPHINE SULFATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL70","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arymo er","Astramorph pf","Avinza","Depodur","Duramorph","Duramorph pf","Duromorph","Filnarine sr","Infumorph","Kadian","Moraxen","Morcap sr","Morphabond","Morphabond er","Morphgesic sr","Morphine sulfate","Morphine sulfate (autoinjector)","Ms contin","Mst continus","Oramorph","Oramorph sr","Oramorph udv","Rhotard","Sevredol","Srm-rhotard","Zomorph"],"synonyms":["Morphine sulfate","Morphine sulfate anhydrous","Morphine sulfate cii","Morphine sulfate hydrate","Morphine sulfate pentahydrate","NSC-11441"],"crossReferences":{"DailyMed":["morphine%20sulfate"],"PubChem":["144206414"],"chEBI":["50731"]},"count":13,"approvedIndications":["HP_0012532","EFO_0003843","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","HP_0000989","EFO_0001361","HP_0012532","Orphanet_232","EFO_0000768","HP_0003418","EFO_0003818","EFO_0003843","MONDO_0004565","EFO_0000311","EFO_0003964","EFO_0003931","EFO_1000786","EFO_0004616","HP_0003419","EFO_0000612","EFO_0005611","EFO_0005799","EFO_0003918","HP_0001822","MONDO_0024880","EFO_0005672"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104047","canonicalSmiles":"C[C@H](N)C(=O)c1ccccc1","inchiKey":"PUAQLLVFLMYYJJ-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CATHINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cathinone"],"crossReferences":{"PubChem":["124893451"],"drugbank":["DB01560"],"chEBI":["4110"]},"childChemblIds":["CHEMBL3182836"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104406","canonicalSmiles":"COc1cc(C(=O)C(=O)N2CCCC[C@H]2C(=O)OC(CCCc2cccnc2)CCCc2cccnc2)cc(OC)c1OC.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"VDMKJSJJXQDICL-ZXVJYWQYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIRICODAR DICITRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL350775","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biricodar dicitrate","VX-710","VX-710-3","VX-71O-3"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104871","canonicalSmiles":"CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1.Cl","inchiKey":"FEWCTJHCXOHWNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXATIDINE ACETATE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL46102","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HOE 062 [ROXATIDINE]","HOE 760","Roxatidine acetate hydrochloride"],"crossReferences":{"PubChem":["144206053","144206507","170465941","49681593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104910","canonicalSmiles":"CC(C)=CC(=O)NS(=O)(=O)c1ccc(N)cc1","inchiKey":"XRVJPLDTMUSSDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADICRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfadicramide","Sulfadicrolamide"],"crossReferences":{"drugbank":["DB13214"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105965","canonicalSmiles":"CC1=C(c2ccc(O)cc2)[C@H](c2ccc(OCCN3CCCCC3)cc2)Oc2cc(O)ccc21.Cl","inchiKey":"BYQDPIXWTVEVEA-JMAPEOGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOLBIFENE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL68055","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acolbifene hydrochloride","SCH-57068 HYDROCHLORIDE","SCH57068 HCL","SCH57068.HCL"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106411","canonicalSmiles":"CC[C@@H](C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"SBFXHXZNBNFPHV-PXXBSISHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPICRIPTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epicriptine"],"crossReferences":{"drugbank":["DB11275"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106439","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1","inchiKey":"KTOYYUONFQWSMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPOTIAZINE PALMITATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Piportil depot"],"synonyms":["IL-19552","Pipotiazine","Pipotiazine palmitate","RP 19552"],"crossReferences":{"PubChem":["144206970"]},"count":1,"approvedIndications":["EFO_0005407"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psychosis."}
{"id":"CHEMBL2107869","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN DEGLUDEC","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ins tresiba","Tresiba"],"synonyms":["Insulin degludec","NN-1250","NN1250"],"crossReferences":{"DailyMed":["insulin%20degludec"],"DrugCentral":["4960"]},"count":3,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0001359","EFO_0001360","EFO_0000400"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for diabetes mellitus and has 2 investigational indications."}
{"id":"CHEMBL2107881","drugType":"Protein","blackBoxWarning":false,"name":"REGRAMOSTIM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GM-CSF","GM-CSF (CHO CELL)","GMC 89-107","GMC-89-107","RHGM-C","RHGM-CSF","Regramostim"],"count":27,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 27 investigational indications."}
{"id":"CHEMBL2107911","drugType":"Protein","blackBoxWarning":false,"name":"ONERCEPT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Onercept","R-HTBP-1"],"count":1,"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0003778"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107917","drugType":"Antibody","blackBoxWarning":false,"name":"OREGOVOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ovarex"],"synonyms":["Oregovamab","Oregovomab","mAb-B43.13"],"count":5,"linkedTargets":{"rows":["ENSG00000181143"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","EFO_1000044","EFO_0003893","EFO_0001075","MONDO_0008170","MONDO_0002087"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108286","drugType":"Protein","blackBoxWarning":false,"name":"TUROCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Turoctocog alfa"],"crossReferences":{"DrugCentral":["5019"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108466","drugType":"Unknown","blackBoxWarning":false,"name":"GINKGO","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B1260","EGB 761","EGB-761","Ginkgo","Ginkgo biloba extract","Ginkgo biloba leaf","Ginkgo biloba leaf dry extract","Ginkgo biloba leaf extract","Ginkgo biloba leaf tincture"],"count":14,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL2108589","drugType":"Antibody","blackBoxWarning":false,"name":"CLAZAKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALD-518","ALD518","BMS-945429","Clazakizumab"],"count":8,"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0100096","EFO_0000270","HP_0004326","EFO_0003778","HP_0012378","EFO_0004599","EFO_0000384","EFO_1001904"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2108663","drugType":"Gene","blackBoxWarning":false,"name":"VELIMOGENE ALIPLASMID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Allovectin"],"synonyms":["Velimogene aliplasmid"],"count":1,"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108764","drugType":"Unknown","blackBoxWarning":false,"name":"PROTHROMBIN COMPLEX, ACTIVATED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prothrombin complex, activated"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108793","drugType":"Enzyme","blackBoxWarning":false,"name":"TILACTASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-galactosidase (aspergillus)","G9S0VV191I","Galactosidase","Tilactase"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108967","drugType":"Antibody","blackBoxWarning":false,"name":"LERDELIMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Trabio"],"synonyms":["CAT-152","Lerdelimumab","TRABIO"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2109037","drugType":"Protein","blackBoxWarning":false,"name":"ILODECAKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tenovil"],"synonyms":["Ilodecakin","Interleukin-10 ilodecakin","Prevascar","SCH 52000","SCH-52000"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109396","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-888","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-888","U3-1287"],"count":3,"linkedTargets":{"rows":["ENSG00000065361"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0003060"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109545","drugType":"Antibody","blackBoxWarning":false,"name":"TB-403","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7334","RO-5323441","TB-403","TB403","THR-317","Tb-403","Thr 317"],"count":1,"linkedTargets":{"rows":["ENSG00000119630"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109555","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-070","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDX-070"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109566","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-557","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-557","Medi-557"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109608","drugType":"Antibody","blackBoxWarning":false,"name":"L19IL2","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L19IL2"],"count":4,"linkedTargets":{"rows":["ENSG00000115414"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0000756","EFO_0002617"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109615","drugType":"Antibody","blackBoxWarning":false,"name":"MRA 003 US","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MRA 003 US","Mra 003 us"],"count":1,"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110703","canonicalSmiles":"CCNC1(c2cccs2)CCCCC1=O","inchiKey":"QAXBVGVYDCAVLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tiletamine"],"crossReferences":{"drugbank":["DB11549"]},"childChemblIds":["CHEMBL2105342"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110737","canonicalSmiles":"CCCC(=O)O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O","inchiKey":"HTJGLYIJVSDQAE-VWNXEWBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CELGOSIVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Celgosivir"],"crossReferences":{"drugbank":["DB06580"]},"childChemblIds":["CHEMBL2105801"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2141712","canonicalSmiles":"COc1ccc(COc2cc3oc(=O)c4cc(C(C)O)ccc4c3cc2OC)cc1","inchiKey":"YEAHTLOYHVWAKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALOMID-529","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-529","P529","PALOMID-529","Palomid-529","SG 00529","SG-00529"],"crossReferences":{"PubChem":["137275969"],"drugbank":["DB12812"]},"count":1,"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0001365"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2146883","canonicalSmiles":"O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1","inchiKey":"BSMCAPRUBJMWDF-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COBIMETINIB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cotellic"],"synonyms":["Cobimetinib","GDC-0973","Gdc-0623","RG 7420","RG-7420","RG7420","Rg-7420","Rg-7421","XL-518"],"crossReferences":{"DailyMed":["cobimetinib%20fumarate"],"drugbank":["DB05239"]},"childChemblIds":["CHEMBL2364607","CHEMBL3526209"],"count":17,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000756","MONDO_0007254","EFO_1000209","EFO_1000984","EFO_1001951","EFO_1001480","EFO_1000044","EFO_1000218","EFO_0000389","EFO_1000532","EFO_0002617","EFO_0000616","EFO_1001779","MONDO_0021058","EFO_0002916","EFO_0000503","MONDO_0008170","EFO_0000222","EFO_1000088","EFO_0003060","EFO_0000311","EFO_1000489","MONDO_0002529","EFO_0002517","MONDO_0003219","EFO_0001378","MONDO_0024880","EFO_0000691"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for cancer and neoplasm and has 15 investigational indications."}
{"id":"CHEMBL216146","canonicalSmiles":"Cn1c(=O)ccc2ccccc21","inchiKey":"QYEMNJMSULGQRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216146","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04580"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222002","canonicalSmiles":"CCOCCC1(Oc2ccc(Oc3ccc(F)cc3)cc2)C(=O)NC(=O)NC1=O","inchiKey":"XRSYNYGEEYTXJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL222002","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08388"],"chEBI":["45030"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233295","canonicalSmiles":"COc1ccc(/C=C/C(=O)O)cc1O","inchiKey":"QURCVMIEKCOAJU-HWKANZROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOFERULIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoferulic Acid"],"crossReferences":{"PubChem":["56314647"],"drugbank":["DB07109"],"chEBI":["27794"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2360464","canonicalSmiles":"Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+]","inchiKey":"NYDXNILOWQXUOF-GXKRWWSZSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMETREXED DISODIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL225072","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alimta"],"synonyms":["LY-231514 DISODIUM SALT","LY231514 DISODIUM SALT","Pemetrexed disodium","Pemetrexed disodium heptahydrate","Pemetrexed sodium hydrate","Pemetrexed sodium salt"],"crossReferences":{"DailyMed":["pemetrexed%20disodium"],"PubChem":["144206040"],"chEBI":["63722"]},"count":31,"approvedIndications":["EFO_0003060"],"linkedTargets":{"rows":["ENSG00000176890","ENSG00000228716","ENSG00000159131"],"count":3},"linkedDiseases":{"rows":["EFO_0000365","MONDO_0004192","EFO_0000571","MONDO_0021117","MONDO_0007254","EFO_0000708","MONDO_0002087","EFO_0000308","MONDO_0020654","EFO_1001951","MONDO_0001187","MONDO_0001056","MONDO_0002158","EFO_0000588","EFO_0003860","MONDO_0002974","EFO_0000770","MONDO_0008903","EFO_0008528","EFO_0000616","EFO_0002618","EFO_0006859","Orphanet_59305","MONDO_0008170","EFO_0003060","MONDO_0008315","EFO_1000124","EFO_0000311","EFO_0009708","EFO_0003863","EFO_1000576","EFO_1000581","MONDO_0011962","EFO_0000233","EFO_0000574","MONDO_0024880","EFO_0000691","EFO_0003050"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for non-small cell lung carcinoma and has 30 investigational indications."}
{"id":"CHEMBL236297","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(=O)c(c5oc6cc(N7CCN(CC(C)C)CC7)cc(O)c6nc-5c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C","inchiKey":"UEFHFKKWYKVLDC-HTQYORAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFALAZIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KRM-1648","Rifalazil"],"crossReferences":{"drugbank":["DB04934"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2364625","canonicalSmiles":"O=C([O-])C[C@H]1CC[C@H](c2ccc(-c3ccc(Nc4ccc(C(F)(F)F)nc4)cn3)cc2)CC1.[Na+]","inchiKey":"MUZRGKSNUTWRAF-BHQIMSFRSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADIGASTAT SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2364624","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LCQ-908-ABA","LCQ-908ABA","LCQ908-ABA","LCQ908A","Lcq908a","Pradigastat sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2365707","canonicalSmiles":"C[C@H](CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1","inchiKey":"INUNXTSAACVKJS-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2365707","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01529"],"chEBI":["74274"]},"childChemblIds":["CHEMBL2362682"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24547","canonicalSmiles":"O=C(O)[C@H](Cc1ccccc1)N(Cc1cccc(C(F)(F)F)c1)C(=O)c1ccc(Cl)cc1Cl","inchiKey":"LAJJKGIZTCCOHY-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL24547","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03605"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24991","canonicalSmiles":"C[S+](CCC(N)C(=O)[O-])C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"MEFKEPWMEQBLKI-YDBXVIPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-ADENOSYL-L-METHIONINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-adenosyl-l-methionine"],"crossReferences":{"Wikipedia":["S-Adenosyl_methionine"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL253144","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"WHBHBVVOGNECLV-OBQKJFGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORTODOXONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["11-Deoxycortisol","11-desoxy-17-hydroxycorticosterone","Cortexolone","Cortodoxone","NSC-18317","SK&F 3050"],"crossReferences":{"PubChem":["144204418","170466572","50103892","50103893","56320663","855521","90340938"],"Wikipedia":["Cortodoxone"],"chEBI":["28324"]},"childChemblIds":["CHEMBL1256713"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL254951","canonicalSmiles":"OCCS","inchiKey":"DGVVWUTYPXICAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-MERCAPTOETHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Mercaptoethanol","Beta-Mercaptoethanol"],"crossReferences":{"Wikipedia":["2-Mercaptoethanol"],"drugbank":["DB03345"],"chEBI":["41218"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260000","canonicalSmiles":"NCC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1","inchiKey":"KCWPSUKJCKZEAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL260000","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08149"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL268869","canonicalSmiles":"COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1","inchiKey":"VLYWMPOKSSWJAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMETHOXYPYRIDAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"year":1986},"tradeNames":["Lederkyn","Midicel","Succinylsulfathi","Sulfasuxidine"],"synonyms":["Sulfamethoxypyridazine","Sulphamethoxypyridazine"],"crossReferences":{"PubChem":["11112213","144203924","170466374","7971832","855697"],"Wikipedia":["Sulfamethoxypyridazine"],"drugbank":["DB13773"],"chEBI":["102516"]},"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease. It was withdrawn in United Kingdom  in 1986."}
{"id":"CHEMBL271220","canonicalSmiles":"CCOC[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CCN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2","inchiKey":"SLKURXRZHJOZOD-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORT 108297","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cort 108297"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289422","canonicalSmiles":"O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1[C@H]1CC[C@@H]3O1","inchiKey":"OTPNDVKVEAIXTI-IYBDPMFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL289422","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292439","canonicalSmiles":"CCCC[C@H](N)C(=O)O","inchiKey":"LRQKBLKVPFOOQJ-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORLEUCINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-Hexanoic Acid","NSC-10378","Norleucine"],"crossReferences":{"drugbank":["DB15458"],"chEBI":["18347"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL299613","canonicalSmiles":"COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12","inchiKey":"CQOQDQWUFQDJMK-SSTWWWIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-METHOXYESTRADIOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-methoxyestradiol","NSC-659853"],"crossReferences":{"PubChem":["11532969","124891665","50106559","50106560","56423644","90340800"],"Wikipedia":["2-Methoxyestradiol"],"drugbank":["DB02342"],"chEBI":["28955"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL303296","canonicalSmiles":"CC(C)C[C@H](N)C(=O)NO","inchiKey":"UJJHPFLWSVFLBE-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303296","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03308"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL307747","canonicalSmiles":"O=C(N[C@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1","inchiKey":"XYUFCXJZFZPEJD-PGRDOPGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL307747","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04098"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3120215","canonicalSmiles":"COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12","inchiKey":"JROFGZPOBKIAEW-HAQNSBGRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSI-027","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OSI-027","Osi 027","Osi-027"],"crossReferences":{"drugbank":["DB12387"]},"count":1,"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL312443","canonicalSmiles":"Oc1noc2c1CCNC2","inchiKey":"ZXRVKCBLGJOCEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GABOXADOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gaboxadol","LU 02-030","LU-02-030","LU-02030","MK-0928"],"crossReferences":{"PubChem":["104171241","11111836","11111837","11113715","170466512","90341079"],"Wikipedia":["Gaboxadol"],"drugbank":["DB06554"],"chEBI":["34373"]},"childChemblIds":["CHEMBL1255746"],"count":4,"linkedTargets":{"rows":["ENSG00000022355","ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000186297","ENSG00000166206","ENSG00000163288"],"count":9},"linkedDiseases":{"rows":["MONDO_0002009","Orphanet_72","EFO_0004698","Orphanet_908"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3137349","drugType":"Antibody","blackBoxWarning":false,"name":"BOCOCIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bococizumab","PF-04950615","RN-316","RN316"],"count":4,"linkedTargets":{"rows":["ENSG00000169174"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0003774","EFO_0000319","EFO_0004911"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3183114","canonicalSmiles":"CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1.Cl","inchiKey":"ZMROYCGIWPNZNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183114","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1474889","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205220","170466051"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3235279","canonicalSmiles":"N#Cc1c(N)nc(SCc2csc(-c3ccc(Cl)cc3)n2)c(C#N)c1-c1ccc(OCCO)cc1","inchiKey":"CITWCLNVRIKQAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPADENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 68-4986","BAY-68-4986","Bay-684986","Capadenoson"],"count":2,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003913"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3250772","canonicalSmiles":"O=S(=O)(O)O.[2H]C([2H])([2H])C([2H])(N)C([2H])([2H])c1ccccc1","inchiKey":"SOFQDLYSFOWTJX-FQZUOFASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250772","maximumClinicalTrialPhase":0,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3250774","canonicalSmiles":"O=S(=O)(O)O.[2H]C(c1ccccc1)C(C)N","inchiKey":"SOFQDLYSFOWTJX-DRGWXPQLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250774","maximumClinicalTrialPhase":0,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301612","canonicalSmiles":"COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1","inchiKey":"CMJCXYNUCSMDBY-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCORAFENIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Braftovi"],"synonyms":["Encorafenib","Lgx-818","NVP-LGX-818-NXA","NVP-LGX818","NVP-LGX818-NXA"],"crossReferences":{"DailyMed":["encorafenib"],"drugbank":["DB11718"]},"count":10,"approvedIndications":["EFO_0000616","EFO_0000756","EFO_0002617","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_1001480","EFO_0000365","EFO_1000956","EFO_0002892","EFO_0000756","EFO_0001378","EFO_0003060","EFO_0002617","EFO_0000311","EFO_1001951"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 4 approved and 6 investigational indications."}
{"id":"CHEMBL331237","canonicalSmiles":"Cn1nc(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23","inchiKey":"HOGVTUZUJGHKPL-HTVVRFAVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICIRIBINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-154020"],"crossReferences":{"PubChem":["144204743","170466256","26753208"],"drugbank":["DB12405"],"chEBI":["65310"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3350399","canonicalSmiles":"O=[14C]1O[C@H]([C@@H](O)CO)C(O)=C1O","inchiKey":"CIWBSHSKHKDKBQ-SKVAQFBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3350399","maximumClinicalTrialPhase":0,"parentId":"CHEMBL196","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527581","canonicalSmiles":"N=[14C](N)N1CCc2ccccc2C1","inchiKey":"JWPGJSVJDAJRLW-HRVHXUPCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3527581","maximumClinicalTrialPhase":0,"parentId":"CHEMBL169901","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544916","canonicalSmiles":"Nc1ncn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3O)[C@@H](CO)O2)c(=O)n1","inchiKey":"GUWXKKAWLCENJA-WGWHJZDNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUADECITABINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guadecitabine","SGI-110"],"crossReferences":{"drugbank":["DB11918"]},"childChemblIds":["CHEMBL3544980"],"count":13,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL3544927","drugType":"Small molecule","blackBoxWarning":false,"name":"L-21649","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-21649"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544975","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NCC1CCN(CC[C@H](OC(N)=O)c2ccc(F)cc2)CC1","inchiKey":"KGMMSPVVHZGPHL-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELENOPRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Relenopride","YKP-10811","YKP10811"],"crossReferences":{"drugbank":["DB12798"]},"childChemblIds":["CHEMBL3544976"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545027","canonicalSmiles":"COC(=O)Nc1nc2cc(C3(O)c4ccccc4C(=O)N3c3cc(Cl)ccc3C)ccc2[nH]1","inchiKey":"MMNNTJYFHUDSKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-281","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-908662","EXEL-2819","Xl-281"],"crossReferences":{"drugbank":["DB12854"]},"count":4,"linkedTargets":{"rows":["ENSG00000157764","ENSG00000132155"],"count":2},"linkedDiseases":{"rows":["EFO_0000756","EFO_0000641","EFO_0003060","EFO_1001951"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545054","drugType":"Small molecule","blackBoxWarning":false,"name":"INCB-40093","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-040093","Incb-40093"],"count":2,"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0000183","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545142","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOCROLIMUS","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sar-943"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545274","canonicalSmiles":"CC(C)(C)n1nnc2c3c(ccc21)C1=CC(=O)CC[C@@]1(CCOc1ccccc1)C3","inchiKey":"LYLIIGQPIKTONH-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-6913","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-6913"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545332","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-2563","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cep-2563"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545333","canonicalSmiles":"CN1C(=O)C(F)=C[C@]2(C)C3CC[C@@]4(C)C(CC[C@@H]4C(=O)NCc4nc5ncccc5[nH]4)C3CCC12","inchiKey":"GBEUKTWTUSPHEE-PAWGCEJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0773","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-0773","PF-05314882"],"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_1000653"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545360","canonicalSmiles":"COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1","inchiKey":"MGGBYMDAPCCKCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASP-3026","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP3026","Asp 3026","Asp-3026"],"crossReferences":{"drugbank":["DB12729"]},"count":2,"linkedTargets":{"rows":["ENSG00000171094"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000096"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL356637","canonicalSmiles":"[2H]c1c([2H])c(C(C)C)c(O)c(C(C)C)c1[2H]","inchiKey":"OLBCVFGFOZPWHH-CRSPMMAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIDEUTERATED PROPOFOL","maximumClinicalTrialPhase":0,"parentId":"CHEMBL526","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trideuterated Propofol"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL357488","canonicalSmiles":"COC(=O)c1cc(C[C@H](NC(C)=O)C(=O)N[C@H]2CCCCN(Cc3ccc(-c4ccccc4)cc3)C2=O)ccc1C(F)(C(=O)O)C(=O)O","inchiKey":"RLLAUERCSKPFGD-VMPREFPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL357488","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02432"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL367465","canonicalSmiles":"CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1.[K+].[OH-]","inchiKey":"BOXLCNYKQAJDCL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL367465","maximumClinicalTrialPhase":0,"parentId":"CHEMBL191","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707289","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O","inchiKey":"TZGKQIBPZOZAKF-PJLVGBPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROERGOCRYPTINE MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1743263","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydroergocryptine mesylate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707302","canonicalSmiles":"CC(=O)CCC(=O)[O-].CC(=O)CCC(=O)[O-].[Mg+2]","inchiKey":"RECCGACJWKEPOU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM LEVULINATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1235931","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium levulinate"],"crossReferences":{"DrugCentral":["4593"],"drugbank":["DB14514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707353","drugType":"Small molecule","blackBoxWarning":false,"name":"RG7893","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0276","Rg7893"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707392","canonicalSmiles":"O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1","inchiKey":"YNUAEEJQYHYLMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELECLAZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eleclazine","GS-6615"],"crossReferences":{"drugbank":["DB12394"]},"childChemblIds":["CHEMBL3972607"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL372832","canonicalSmiles":"COc1ccccc1-c1ccc(C(=O)O)o1","inchiKey":"CHWVDGYLKPLBES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372832","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29215075","4242327"],"drugbank":["DB07407"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL375270","canonicalSmiles":"O=C(Nc1ccccc1)c1cc([N+](=O)[O-])ccc1Cl","inchiKey":"DNTSIBUQMRRYIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW9662","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW9662"],"crossReferences":{"PubChem":["11114114","124880752","124880754","124880755","124880756","144212310","26732595","26752210","26752211","50104878","85231138","90341221"],"drugbank":["DB07863"],"chEBI":["79993"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL375951","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"HSCJRCZFDFQWRP-JZMIEXBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE DIPHOSPHATE GLUCOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-Diphosphoglucose","UDPG","Udp-Glucose","Uridine Diphosphate Glucose","Uridine-5'-Diphosphoglucose"],"crossReferences":{"Wikipedia":["Uridine_diphosphate_glucose"],"drugbank":["DB01861"],"chEBI":["46229"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL377956","canonicalSmiles":"Nc1ccc2[nH]c(-c3cc(CC(=O)O)cc(-c4cccc([N+](=O)[O-])c4)c3O)cc2n1","inchiKey":"BVBGZXXLVHYBKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL377956","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08232"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833325","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)[O-].CC(=O)Oc1ccccc1C(=O)[O-].NC(N)=O.[Ca+2]","inchiKey":"VYMUGTALCSPLDM-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBASPIRIN CALCIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3833404","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbasalate calcium","Carbaspirin calcium"],"crossReferences":{"DrugCentral":["4387"],"drugbank":["DB13612"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3833347","canonicalSmiles":"CC(=O)NC(CCC(=O)O)C(=O)O.CN(C)CCO","inchiKey":"WKAVKKUXZAWHDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEANOL ACEGLUMATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2142890","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Deanol","Deanol aceglumate"],"count":1,"approvedIndications":["EFO_0003888"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for attention deficit hyperactivity disorder."}
{"id":"CHEMBL3833357","drugType":"Antibody","blackBoxWarning":false,"name":"BEGELOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Begedina"],"synonyms":["BT 5/9","Begelomab","SAND-26"],"count":2,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000540"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3957601","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)N[O-])cc23)c1.[Na+]","inchiKey":"BENZEMKVZQJZTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3957601","maximumClinicalTrialPhase":0,"parentId":"CHEMBL598797","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989727","drugType":"Small molecule","blackBoxWarning":false,"name":"VITAMIN E","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alpha Tocopherol","Aquasol e","Bio-e-vit","Davina","E-caps","Eprolin","Fort-e-vite","Fort-e-vite 1000","Fort-e-vite plus","Fort-e-vite super plus","Harris","Jarrow for","Natopherol","Sigma","Tocopherol"],"synonyms":["Alpha-tocopherol","J203.513H","Tocopherol","Tocopherol (vit e)","Tocopheryl acetate, d-alpha","Tocopheryl acetate, dl-alpha","Tocopheryl acid succinate, d-alpha","Vitamin e"],"crossReferences":{"DailyMed":["vitamin%20e"]},"count":67,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 67 investigational indications."}
{"id":"CHEMBL3989843","canonicalSmiles":"N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1","inchiKey":"IGLYMJRIWWIQQE-QUOODJBBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRANYLCYPROMINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-80664","Tranylcypromine"],"crossReferences":{"DailyMed":["tranylcypromine%20sulfate"]},"childChemblIds":["CHEMBL3989698"],"count":8,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000289","MONDO_0002050","MONDO_0002009","HP_0000726","EFO_0005252","EFO_0003761","EFO_0000222","EFO_0005230","EFO_0000692"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for unipolar depression and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989870","canonicalSmiles":"CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1","inchiKey":"JZCWLJDSIRUGIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERZOSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berzosertib","M-6620","M6620","VE-822","VX-970","VX970","Vx-970"],"crossReferences":{"drugbank":["DB11794"]},"count":10,"linkedTargets":{"rows":["ENSG00000175054"],"count":1},"linkedDiseases":{"rows":["EFO_0001416","EFO_0000616","EFO_0003893","EFO_0001075","EFO_1001958","MONDO_0015686","MONDO_0008170","EFO_1001973","MONDO_0044704","EFO_0003060","EFO_0000304","EFO_1000251","EFO_0000196","EFO_0000702","EFO_0006544","MONDO_0024880"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3989885","canonicalSmiles":"CC(CN(C)C)CN1c2ccccc2Sc2ccccc21.CC(CN(C)C)CN1c2ccccc2Sc2ccccc21.O=C(O)C(O)C(O)C(=O)O","inchiKey":"AJZJIYUOOJLBAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMEPRAZINE TARTRATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL829","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Temaril","Trimeprazine tartrate","Vallergan","Vallergan fte"],"synonyms":["Alimemazine tartrate","Trimeprazine tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3989932","canonicalSmiles":"CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"VBTZKFAHKJXHBA-PIONDTTLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ANGIOTENSIN II ACETATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL408403","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Giapreza"],"synonyms":["Angiotensin ii acetate"],"crossReferences":{"DailyMed":["angiotensin%20ii%20acetate"]},"count":1,"approvedIndications":["EFO_0006834"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0006834"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for septic shock."}
{"id":"CHEMBL3990000","drugType":"Antibody","blackBoxWarning":false,"name":"TIBULIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3090106","LY3090106","Tibulizumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL402761","canonicalSmiles":"O=C(Nc1ccccc1S(=O)(=O)Nc1ccc(Cl)cn1)c1ccc(-n2ccccc2=O)cc1","inchiKey":"MIJGLXFQYBTIFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL402761","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07800"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL404","canonicalSmiles":"C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O","inchiKey":"LPQZKKCYTLCDGQ-WEDXCCLWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAZOBACTAM","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CL 298,741","CL-298741","Tazobactam","YTR-830H"],"crossReferences":{"DailyMed":["tazobactam%20sodium"],"Wikipedia":["Tazobactam"],"drugbank":["DB01606"],"chEBI":["9421"]},"childChemblIds":["CHEMBL1439"],"count":21,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for bacterial disease and has 20 investigational indications."}
{"id":"CHEMBL4078588","canonicalSmiles":"Cc1ccc(Cc2cc3c(=O)n([C@H]4CCCC[C@@H]4O)cnc3c3ccccc23)cn1","inchiKey":"JUVQLZBJFOGEEO-GOTSBHOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-7622","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK7622","Mk-7622"],"crossReferences":{"drugbank":["DB12897"]},"childChemblIds":["CHEMBL4216833"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL407874","canonicalSmiles":"Nc1nc(OCc2ccccc2)c2nc[nH]c2n1","inchiKey":"KRWMERLEINMZFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6-O-BENZYLGUANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-o-benzylguanine","NSC-637037","O6-benzylguanine"],"crossReferences":{"PubChem":["11110835","46500408","49674655","498466","50105918","50105919","85230936","90341638"],"drugbank":["DB11919"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL41355","canonicalSmiles":"CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N","inchiKey":"PCOBBVZJEWWZFR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZOGABINE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Potiga","Trobalt"],"synonyms":["AWD-21360","AWD21-360","D-23129","Ezogabine","GKE-841","GW-582892X","GW582892X","Retigabine","WAY-143841"],"crossReferences":{"PubChem":["174006313"],"Wikipedia":["Retigabine"],"drugbank":["DB04953"],"chEBI":["68584"]},"count":6,"approvedIndications":["EFO_0000474","HP_0001250"],"linkedTargets":{"rows":["ENSG00000117013","ENSG00000053918","ENSG00000184156","ENSG00000185760","ENSG00000075043"],"count":5},"linkedDiseases":{"rows":["EFO_0000474","MONDO_0002050","MONDO_0002009","EFO_0006510","EFO_0000253","HP_0001250"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for seizure and epilepsy and has 4 investigational indications."}
{"id":"CHEMBL4208954","canonicalSmiles":"NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"FXKSEJFHKVNEFI-GCZBSULCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMIKACIN SULFATE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL177","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amiglyde","Amikacin sulfate","Amikin","Arikayce kit"],"synonyms":["Amikacin sulfate","BB-K8"],"crossReferences":{"DailyMed":["amikacin%20sulfate"]},"count":8,"approvedIndications":["EFO_0005681","HP_0100806","EFO_0000584","EFO_0003103","EFO_0008588","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 6 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL424278","canonicalSmiles":"CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)NC(=O)CCl)CO2","inchiKey":"MSHZHSPISPJWHW-PVDLLORBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"O-CHLOROACETYLCARBAMOYLFUMAGILLOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGM-1470","NSC-642492","O-chloroacetylcarbamoylfumagillol","TNP-470","Tnp-470"],"crossReferences":{"PubChem":["501161"],"drugbank":["DB08633"],"chEBI":["90748"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4280145","canonicalSmiles":"Oc1cc2c(cc1O)[C@@H]1c3ccccc3CN[C@H]1CC2","inchiKey":"BGOQGUHWXBGXJW-YOEHRIQHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4280145","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12890"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297091","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O.O.O=S(=O)(O)O","inchiKey":"BOLDZXRCJAJADM-AAXBYHQXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CODEINE SULFATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL485","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Codeine sulfate"],"synonyms":["Codeine sulfate","Codeine sulfate cii"],"crossReferences":{"DailyMed":["codeine%20sulfate"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2009 and is indicated for pain. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297201","drugType":"Small molecule","blackBoxWarning":false,"name":"CHROMIUM PICOLINATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL3185022","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chromium picolinate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297236","drugType":"Gene","blackBoxWarning":false,"name":"LISOCABTAGENE MARALEUCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JCAR-017","JCAR017","Lisocabtagene maraleucel"],"count":6,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297315","canonicalSmiles":"N=C(N)c1ccc2nc(-c3cc(CC(=O)N[C@@H](CC(=O)O)C(=O)O)cc(-c4cc(S(N)(=O)=O)ccc4O)c3O)[nH]c2c1","inchiKey":"WDJHHCAKBRKCLW-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PCI-27483","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pci-27483"],"crossReferences":{"drugbank":["DB13000"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297324","canonicalSmiles":"COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"UNLWPYSYFQLJSV-LMOVPXPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMIMAZOLAM TOSYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4297526","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Remimazolam tosylate"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297418","canonicalSmiles":"Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](COC(=O)CO)C3)c2n1","inchiKey":"ZBBZROWQLKCFQK-KOLCDFICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABACAVIR HYDROXYACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abacavir hydroxyacetate","Prurisol"],"crossReferences":{"drugbank":["DB12187"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297435","canonicalSmiles":"COC(=O)c1nc(C(F)(F)F)n2c1CN(C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)CC2","inchiKey":"WIIAMRXFUJLYEF-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETAGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Retagliptin","SP-2086","SP2086","Sp2086"],"crossReferences":{"drugbank":["DB14898"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297442","canonicalSmiles":"OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4cccc(F)c4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3cccc(F)c3)nn2)[C@H]1O","inchiKey":"YGIDGBAHDZEYMT-MQFIMZJJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TD-139","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TD139","Td-139","Td139"],"crossReferences":{"drugbank":["DB12895"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297447","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)O","inchiKey":"XIEWFECSPPTVQN-KMIMAYJXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TRV-120027","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trv-120027","Trv120027"],"crossReferences":{"drugbank":["DB12199"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297499","canonicalSmiles":"CC(C)C(=O)OC[C@@]1(N=[N+]=[N-])O[C@@H](n2ccc(N)nc2=O)[C@@H](C)[C@@H]1OC(=O)C(C)C","inchiKey":"XJBILYMRFVHPJB-XJQUKVTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TMC-649128","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TMC-649128","TMC649128","Tmc-649128","Tmc649128"],"crossReferences":{"drugbank":["DB15152"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297522","canonicalSmiles":"CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3[nH]c(CN4CCOCC4)cc3c21","inchiKey":"HCDMJFOHIXMBOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMIGATINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pemazyre"],"synonyms":["INCB054828","Incb054828","Pemigatinib"],"crossReferences":{"DailyMed":["pemigatinib"],"drugbank":["DB15102"]},"count":7,"approvedIndications":["EFO_0005221"],"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003863","EFO_0004251","MONDO_0011962","EFO_0008528","EFO_0000222","EFO_0005221","EFO_0000311","MONDO_0001187"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for cholangiocarcinoma and has 6 investigational indications."}
{"id":"CHEMBL4297523","canonicalSmiles":"COc1ccc2[nH]cc(CCNC(=O)c3cc(=O)cco3)c2c1","inchiKey":"PNTNBIHOAPJYDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIROMELATINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NEU-P-11","NEU-P11","Neu-p11","Piromelatine"],"crossReferences":{"drugbank":["DB12288"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297525","canonicalSmiles":"NC(=O)C1(NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2csc3ccccc23)NC(=O)C2CCNCC2)CCNCC1","inchiKey":"KUBPNVYPKPWGRJ-LIVOIKKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELAMORELIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIM-28131","BIM28131","Relamorelin"],"crossReferences":{"drugbank":["DB12678"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297592","canonicalSmiles":"Cc1cccc(C)c1N(CC(=O)Nc1ccc(-c2ncon2)cc1)C(=O)C1CCS(=O)(=O)CC1","inchiKey":"MNHNIVNAFBSLLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMENAMEVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-2151","ASP2151","Amenamevir","Asp2151"],"crossReferences":{"drugbank":["DB11701"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297655","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC/C=C\\CCCCCCCC)OC(=O)CCCCCCCCCCC/C=C\\CCCCCCCC","inchiKey":"XDSPGKDYYRNYJI-IUPFWZBJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYL TRIERUCATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glyceryl trierucate"],"crossReferences":{"drugbank":["DB12528"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297947","drugType":"Unknown","blackBoxWarning":false,"name":"SACUBITRIL VALSARTAN SODIUM HYDRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Entresto","LCZ-696","LCZ696","Sacubitril valsartan sodium hydrate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298073","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYETHYLENE GLYCOL, UNSPECIFIED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-1521","INS NO.1521","INS-1521","Macrogol","Polyethylene glycol, unspecified","Polyethylene glycols"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298094","drugType":"Unknown","blackBoxWarning":false,"name":"ARCHEXIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Archexin","RX-0201","RX-201","Rx-0201"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298167","canonicalSmiles":"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1.O=C(O)/C=C\\C(=O)O","inchiKey":"BFENHEAPFWQJFL-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILGOTINIB MALEATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3301607","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Filgotinib maleate","GS-6034"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL430145","canonicalSmiles":"C/C=C1/C(=O)N[C@@H](C(=O)O)[C@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](/C=C/C(C)=C/[C@H](C)[C@H](Cc2ccccc2)OC)[C@H](C)C(=O)N[C@@H](C(=O)O)CCC(=O)N1C","inchiKey":"GIRIHYQVGVTBIP-NJYUBDSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTUPORIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Motuporin"],"crossReferences":{"drugbank":["DB04738"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4303352","canonicalSmiles":"C=CC(N)CCC(=O)O.Cl","inchiKey":"FBNKOYLPAMUOHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303352","maximumClinicalTrialPhase":0,"parentId":"CHEMBL89598","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4303682","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O.O=C(O)C(F)(F)F","inchiKey":"FYMJZKAYBCZPKL-PIONDTTLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303682","maximumClinicalTrialPhase":0,"parentId":"CHEMBL408403","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL435747","canonicalSmiles":"Nc1ncccc1NCc1ccccc1","inchiKey":"MUKAGFLFIMVSQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL435747","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07281"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL44833","canonicalSmiles":"N=C(NCCC[C@H](N)C(=O)N[C@@H](CCN)C(N)=O)N[N+](=O)[O-]","inchiKey":"KUZKVXUOMSVPOA-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL44833","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217600"],"drugbank":["DB01821"]},"childChemblIds":["CHEMBL481413","CHEMBL1204421"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL449325","canonicalSmiles":"COc1ccc2nc[nH]c2c1","inchiKey":"ILMHAGCURJPNRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL449325","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04130"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455907","canonicalSmiles":"C[C@H](NC1=NC(=O)[C@](C)(C(C)(C)O)S1)c1ccc(F)cc1","inchiKey":"HYVZYASDRIAOPU-BJOHPYRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL455907","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07017"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594487","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06688992","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06688992","Pf-06688992"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594612","drugType":"Antibody","blackBoxWarning":false,"name":"BEPRANEMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bepranemab","UCB-0107","UCB0107","Ucb0107"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL47527","canonicalSmiles":"Cc1nc(C)c(-c2ccnc(Nc3cccc(O)c3)n2)s1","inchiKey":"JJDRRZFRTKZLFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL47527","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04518"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483716","canonicalSmiles":"CCC1=C[C@@H]2Cc3nc4cc(Cl)ccc4c(N)c3[C@H](C1)C2","inchiKey":"QTPHSDHUHXUYFE-NWDGAFQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL483716","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04114"]},"childChemblIds":["CHEMBL1684446"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485253","canonicalSmiles":"CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1","inchiKey":"KPJZHOPZRAFDTN-NQUBZZJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYSERGIDE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deseril"],"synonyms":["Methysergide"],"crossReferences":{"drugbank":["DB00247"],"chEBI":["584020"]},"childChemblIds":["CHEMBL3989558"],"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000135914","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962 and is indicated for migraine disorder."}
{"id":"CHEMBL501613","canonicalSmiles":"C#CC(C)(O)CC","inchiKey":"QXLPXWSKPNOQLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPARFYNOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dormison","Oblivon"],"synonyms":["Meparfynol","Methylparafynol","Methylpentynol"],"crossReferences":{"PubChem":["144205847"],"drugbank":["DB13733"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL502097","canonicalSmiles":"COCCO[C@H]1[C@@H](O)[C@H](COP(=O)([O-])S[C@H]2[C@H](COP(=O)([O-])S[C@H]3[C@H](COP(=O)([O-])S[C@H]4[C@H](COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)([O-])S[C@H]5C[C@H](n6cnc7c(N)ncnc76)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)([O-])S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5CO)O[C@H](n5cc(C)c(N)nc5=O)[C@H]4OCCOC)O[C@H](n4cnc5c(N)ncnc54)[C@H]3OCCOC)O[C@H](n3cc(C)c(N)nc3=O)[C@H]2OCCOC)O[C@@H]1n1cc(C)c(N)nc1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"OSGPYAHSKOGBFY-KMHHXCEHSA-A","drugType":"Oligonucleotide","blackBoxWarning":true,"name":"MIPOMERSEN SODIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2219536","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kynamro"],"synonyms":["ISIS 301012","ISIS-301012","Mipomersen sodium","Mipomersen sodium salt"],"crossReferences":{"DailyMed":["mipomersen%20sodium"],"Wikipedia":["Mipomersen"]},"count":3,"approvedIndications":["EFO_0000319","EFO_0004911"],"linkedTargets":{"rows":["ENSG00000084674"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0000319","EFO_0004911"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for familial hypercholesterolemia and cardiovascular disease and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL504111","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc([18F])cc1)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C)C(C)C","inchiKey":"LXFYUKLDFCXXMA-IBQCUMGVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"[18F]-FBA-A20FMDV2","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1908904","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[18f]-fba-a20fmdv2"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL509336","canonicalSmiles":"CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1","inchiKey":"YJQZYXCXBBCEAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACTOPAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ractopamine"],"crossReferences":{"PubChem":["26758024"],"Wikipedia":["Ractopamine"],"drugbank":["DB11541"],"chEBI":["82647"]},"childChemblIds":["CHEMBL2105358"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL514315","canonicalSmiles":"CSCC1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)O1","inchiKey":"SRQKTCXJCCHINN-NYYWCZLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURATEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Macmiror","Magmilor","Polmiror","Tydantil"],"synonyms":["Nifuratel"],"crossReferences":{"drugbank":["DB13724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL527066","canonicalSmiles":"Nc1cc(Oc2ccc(NC(=O)NC(=O)Cc3ccc(F)cc3)cc2F)ccn1","inchiKey":"USBSTVPJNQLYEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL527066","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06995"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55960","canonicalSmiles":"Cc1cc(/C=C/c2ccccc2)cc(C)c1O","inchiKey":"PAHKYLUYTGBFNW-CMDGGOBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL55960","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08100"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL577711","canonicalSmiles":"CCCC(CCC)C(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1","inchiKey":"MEOYFIHNRBNEPI-UXIGCNINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2334737","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2334737","LY2334737","Ly-2334737","Ly2334737"],"crossReferences":{"drugbank":["DB12906"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL589370","canonicalSmiles":"Nc1cccc2c(S(=O)(=O)O)cccc12","inchiKey":"DQNAQOYOSRJXFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL589370","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07176"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL59356","canonicalSmiles":"C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)N(O)C(N)=O","inchiKey":"MMSNEKOTSJRTRI-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATRELEUTON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-85761","A-85761.0","ABBOTT-85761","ABT-761","Atreleuton","VIA-2291"],"crossReferences":{"drugbank":["DB12758"]},"count":2,"linkedTargets":{"rows":["ENSG00000012779"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0001645","EFO_0005672"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL596186","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]2O)c(=O)n1","inchiKey":"IERHLVCPSMICTF-CCXZUQQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARA-5'-CMP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ara-5'-cmp","NSC-99445","cytarabine"],"crossReferences":{"drugbank":["DB02456"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL607707","canonicalSmiles":"CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C","inchiKey":"WVUNYSQLFKLYNI-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PELITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EKB-569","Pelitinib","WAY-EKB-569"],"crossReferences":{"PubChem":["50100098"],"drugbank":["DB05524"],"chEBI":["38927"]},"count":4,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000657","EFO_0003060","EFO_0004288"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL62807","canonicalSmiles":"C[C@H]1CCCC[C@@H]1Oc1cccc(-c2nc3cc(C(=N)N)c(F)cc3[nH]2)c1O","inchiKey":"CMCDWLMEDRBWIR-GTNSWQLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL62807","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL638","canonicalSmiles":"C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F","inchiKey":"BCEHBSKCWLPMDN-MGPLVRAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VORICONAZOLE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vfend","Voriconazole"],"synonyms":["UK-109,496","UK-109496","Vfend","Voriconazole"],"crossReferences":{"DailyMed":["voriconazole"],"PubChem":["144205794","170464890","26719857"],"Wikipedia":["Voriconazole"],"drugbank":["DB00582"],"chEBI":["10023"]},"count":16,"approvedIndications":["EFO_0000544","EFO_0007157","EFO_1001282","MONDO_0002026"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 4 approved and 12 investigational indications."}
{"id":"CHEMBL6448","canonicalSmiles":"OCCOCOCc1cc(CCCCCOc2c(Cl)cc(C3=NCCO3)cc2Cl)on1","inchiKey":"JLSNWEWWUSOSMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL6448","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08721"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL69998","canonicalSmiles":"CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1","inchiKey":"FULAPETWGIGNMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIROCOXIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Equioxx"],"synonyms":["Firocoxib","ML-1,785,713"],"crossReferences":{"Wikipedia":["Firocoxib"],"drugbank":["DB09217"],"chEBI":["76136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL701","canonicalSmiles":"NCC(CC(=O)O)c1ccc(Cl)cc1","inchiKey":"KPYSYYIEGFHWSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BACLOFEN","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baclofen","Baclospas-10","Gablofen","Kemstro","Lioresal","Lioresal intrath","Lyflex","Ozobax"],"synonyms":["BA-34,647","BA-34647","Baclofen"],"crossReferences":{"DailyMed":["baclofen"],"PubChem":["104171115","124879423","124879424","170465099","26751712","50104402","85230940","855960","90341690"],"Wikipedia":["Baclofen"],"drugbank":["DB00181"],"chEBI":["2972"]},"childChemblIds":["CHEMBL1897150"],"count":17,"approvedIndications":["HP_0001257","EFO_0003885","EFO_0009488","EFO_1000632"],"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["EFO_1000802","HP_0001257","EFO_0004777","EFO_0002610","HP_0002063","EFO_0009488","EFO_0003758","EFO_0003768","EFO_0001073","EFO_0003843","EFO_0009857","EFO_0003829","EFO_0007191","EFO_0003948","EFO_0003885","EFO_0003890","EFO_0000512","EFO_0000182","EFO_1000632","HP_0003419"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 4 approved and 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL790","canonicalSmiles":"N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1","inchiKey":"GHXZTYHSJHQHIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORHEXIDINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Avagard","Chlorhexidine","Exidine","Hibistat"],"crossReferences":{"DailyMed":["chlorhexidine%20gluconate"],"PubChem":["104171271","11112130","124881938","144203876","144208602","144213755","164339372","170464748","17389113","26752881","56324225","56324718","56463343"],"Wikipedia":["Chlorhexidine"],"drugbank":["DB00878"],"chEBI":["3614"]},"childChemblIds":["CHEMBL1330113","CHEMBL1484251","CHEMBL486819","CHEMBL1628","CHEMBL4297088","CHEMBL2106050"],"count":20,"approvedIndications":["EFO_0000544","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for eye infection and infection and has 18 investigational indications. It was withdrawn in United States."}
{"id":"CHEMBL93645","canonicalSmiles":"O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl","inchiKey":"MNIPYSSQXLZQLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACECLOFENAC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gerbin","Preservex"],"synonyms":["Aceclofenac","Aceclofenac betadex"],"crossReferences":{"PubChem":["11112873","144204261","170465979","50085951"],"Wikipedia":["Aceclofenac"],"drugbank":["DB06736"],"chEBI":["31159"]},"count":6,"approvedIndications":["HP_0002829","HP_0003326","EFO_0000685","EFO_0002506","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["HP_0002829","EFO_0000546","HP_0003326","EFO_1001139","EFO_0000685","EFO_0002506","EFO_0005755"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 approved and 1 investigational indication."}
{"id":"CHEMBL938","canonicalSmiles":"CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C","inchiKey":"PFGWGEPQIUAZME-NXSMLHPHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SARALASIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Saralasin"],"crossReferences":{"Wikipedia":["Saralasin"],"drugbank":["DB06763"]},"childChemblIds":["CHEMBL1200670"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
